Literature DB >> 2138457

Rat heparan sulphates. A study of the antithrombin-binding properties of heparan sulphate chains from rat adipose tissue, brain, carcase, heart, intestine, kidneys, liver, lungs, skin and spleen.

A A Horner1.   

Abstract

Adult male rats were given [35S]sulphate intraperitoneally. Heparan [35S]sulphate (HS) chains were recovered from adipose tissue, brain, carcase, heart, intestine, kidneys, liver, lungs, skin and spleen by digestion with Pronase, precipitation with cetylpyridinium chloride, digestion with chondroitin ABC lyase and DNAase and gradient elution from DEAE-Sephacel. Purity was confirmed by agarose-gel electrophoresis and degradation with HNO2. Fractionation by gradient elution from antithrombin-agarose indicated that the proportion of HS with high binding affinity for antithrombin (HA-HS) ranged from 4.7% (kidneys) to 21.5% (brain). On a mass basis the major sources of HA-HS were carcase, skin and intestine. HA-HS from intestine was arbitrarily divided into subfractions I-VI, with anticoagulant activities ranging from 1 to 60 units/mg [by amidolytic anti-(Factor IIa) assay] and from 4 to 98 units/mg [by amidolytic anti-(Factor Xa) assay], indicating that the antithrombin-binding-site densities of HA-HS chains covered a wide range, as shown previously for rat HA-heparin chains [Horner, Kusche, Lindahl & Peterson (1988) Biochem. J. 251, 141-145]. HA-HS subfractions II, IV and VI were mixed with samples of HA-[3H]heparin chains and rechromatographed on antithrombin-agarose. Affinity for matrix-bound antithrombin did not correlate with anticoagulant activity, e.g. HA-HS subfraction IV [38 anti-(Factor Xa) units/mg] was co-eluted with HA-heparin chains [127 anti-(Factor Xa) units/mg].

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138457      PMCID: PMC1131167     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue.

Authors:  R W Farndale; D J Buttle; A J Barrett
Journal:  Biochim Biophys Acta       Date:  1986-09-04

Review 2.  Structure and function of heparan sulphate proteoglycans.

Authors:  J T Gallagher; M Lyon; W P Steward
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

3.  Anticoagulantly active heparin-like molecules from vascular tissue.

Authors:  J A Marcum; R D Rosenberg
Journal:  Biochemistry       Date:  1984-04-10       Impact factor: 3.162

4.  Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells.

Authors:  J A Marcum; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

5.  Anticoagulant properties in vitro of heparan sulphates.

Authors:  A R Hubbard; C A Jennings; T W Barrowcliffe
Journal:  Thromb Res       Date:  1984-09-01       Impact factor: 3.944

6.  Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.

Authors:  D A Lane; J Denton; A M Flynn; L Thunberg; U Lindahl
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

7.  Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4.

Authors:  D A Lane; G Pejler; A M Flynn; E A Thompson; U Lindahl
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

8.  Biosynthesis of heparin. Effects of n-butyrate on cultured mast cells.

Authors:  K G Jacobsson; J Riesenfeld; U Lindahl
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

9.  Glycosaminoglycan content of glomerular and tubular basement membranes of various mammalian species.

Authors:  F A Reubsaet; J P Langeveld; J H Veerkamp
Journal:  Biochim Biophys Acta       Date:  1985-01-28

10.  Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.

Authors:  J A Marcum; D H Atha; L M Fritze; P Nawroth; D Stern; R D Rosenberg
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

View more
  10 in total

Review 1.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

Review 2.  Proteoglycans of basement membranes.

Authors:  R Timpl
Journal:  Experientia       Date:  1993-05-15

3.  Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species.

Authors:  T Toida; H Yoshida; H Toyoda; I Koshiishi; T Imanari; R E Hileman; J R Fromm; R J Linhardt
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

4.  Endothelial heparan sulphate: compositional analysis and comparison of chains from different proteoglycan populations.

Authors:  A Lindblom; L A Fransson
Journal:  Glycoconj J       Date:  1990       Impact factor: 2.916

5.  Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver.

Authors:  M Lyon; J T Gallagher
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

6.  Domain structure of endothelial heparan sulphate.

Authors:  A Lindblom; G Bengtsson-Olivecrona; L A Fransson
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

Review 7.  Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

Authors:  Bryan E Thacker; Ding Xu; Roger Lawrence; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

8.  Rat liver contains a limited number of binding sites for hepatic lipase.

Authors:  K Schoonderwoerd; A J Verhoeven; H Jansen
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

9.  Heterogeneous distribution of antithrombin-binding sites in rat brain heparan sulphate proteoglycans.

Authors:  A A Horner
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

10.  Effects of aging on the synthesis of antithrombin-binding sites on heparin chains and heparan sulphate chains in the rat.

Authors:  A A Horner
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.